Suppr超能文献

改善胰岛素依赖型糖尿病(IDDM)患者的血糖控制可延缓早期糖尿病肾病形态学变化的进展。

Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy.

作者信息

Bangstad H J, Osterby R, Dahl-Jørgensen K, Berg K J, Hartmann A, Hanssen K F

机构信息

Aker Diabetes Research Centre, Aker University Hospital, Oslo, Norway.

出版信息

Diabetologia. 1994 May;37(5):483-90. doi: 10.1007/s001250050136.

Abstract

We investigated in a randomized, prospective study the influence of improved blood glucose control during 2-3 years in young insulin-dependent diabetic (IDDM) patients with microalbuminuria, which is indicative of early nephropathy. Patients were randomized either to intensive treatment by continuous subcutaneous insulin infusion (CSII) (n = 9) or CT (n = 9). Kidney biopsies were taken at baseline and after 26-34 months. End points were structural changes in the glomeruli. Sensitive, quantitative, morphometric methods were used. The blood glucose control improved significantly (p = 0.01) during the study in the CSII-group as glycated haemoglobin (HbA1c) fell from 10.1% ([95% CI] 8.9-11.3) to 8.6% (7.9-9.2), but not in the CT-group, 10.1% (8.3-11.9) vs 9.7% (8.7-10.8). Mean HbA1c during the study period was significantly lower in the CSII-group than in the CT-group, 8.7% (8.1-9.3) vs 9.9% (8.5-11.3), p = 0.04. Basement membrane thickness (BMT) increased in both groups, most (CT vs CSII, p = 0.03) in the CT-group: 140 nm (50-230) vs CSII: 56 nm (27-86). In the CT-group only an increase was seen in matrix/mesangial volume fraction (p = 0.006) and matrix star volume (p = 0.04). Furthermore, a positive correlation between mean HbA1c during the study and change from baseline in BMT (r = 0.70, p = 0.001) and matrix/glomerular volume fraction (r = 0.33, p = 0.09, NS) was demonstrated. Albumin excretion rate correlated significantly to BMT and most of the matrix parameters.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们进行了一项随机前瞻性研究,调查了在2至3年期间改善血糖控制对患有微量白蛋白尿(这是早期肾病的指标)的年轻胰岛素依赖型糖尿病(IDDM)患者的影响。患者被随机分为持续皮下胰岛素输注(CSII)强化治疗组(n = 9)或常规治疗(CT)组(n = 9)。在基线时和26至34个月后进行肾活检。终点是肾小球的结构变化。使用了灵敏、定量的形态测量方法。在研究期间,CSII组的血糖控制显著改善(p = 0.01),糖化血红蛋白(HbA1c)从10.1%([95%可信区间]8.9 - 11.3)降至8.6%(7.9 - 9.2),而CT组未改善,分别为10.1%(8.3 - 11.9)和9.7%(8.7 - 10.8)。研究期间CSII组的平均HbA1c显著低于CT组,分别为8.7%(8.1 - 9.3)和9.9%(8.5 - 11.3),p = 0.04。两组的基底膜厚度(BMT)均增加,CT组增加最多(CT组与CSII组比较,p = 0.03):140纳米(50 - 230),CSII组为56纳米(27 - 86)。仅在CT组中观察到基质/系膜体积分数增加(p = 0.006)和基质星体积增加(p = 0.04)。此外,研究期间的平均HbA1c与BMT相对于基线的变化之间存在正相关(r = 0.70,p = 0.001)以及与基质/肾小球体积分数之间存在正相关(r = 0.33,p = 0.09,无统计学意义)。白蛋白排泄率与BMT和大多数基质参数显著相关。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验